294 related articles for article (PubMed ID: 19098866)
1. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
Bergmann F; Breinig M; Höpfner M; Rieker RJ; Fischer L; Köhler C; Esposito I; Kleeff J; Herpel E; Ehemann V; Friess H; Schirmacher P; Kern MA
Am J Gastroenterol; 2009 Jan; 104(1):171-81. PubMed ID: 19098866
[TBL] [Abstract][Full Text] [Related]
2. Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors.
Mayer P; Harjung A; Breinig M; Fischer L; Ehemann V; Malz M; Scherübl H; Britsch S; Werner J; Kern MA; Bläker H; Schirmacher P; Bergmann F
Endocr Relat Cancer; 2012 Jun; 19(3):217-32. PubMed ID: 22194440
[TBL] [Abstract][Full Text] [Related]
3. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA
Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481
[TBL] [Abstract][Full Text] [Related]
4. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.
Fjällskog ML; Lejonklou MH; Oberg KE; Eriksson BK; Janson ET
Clin Cancer Res; 2003 Apr; 9(4):1469-73. PubMed ID: 12684421
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
Srivastava A; Alexander J; Lomakin I; Dayal Y
Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256
[TBL] [Abstract][Full Text] [Related]
6. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer.
Lanza-Jacoby S; Burd R; Rosato FE; McGuire K; Little J; Nougbilly N; Miller S
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6161-9. PubMed ID: 17062693
[TBL] [Abstract][Full Text] [Related]
7. Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors.
Shida T; Kishimoto T; Furuya M; Nikaido T; Koda K; Takano S; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Tanizawa T; Nakatani Y; Miyazaki M
Cancer Chemother Pharmacol; 2010 Apr; 65(5):889-93. PubMed ID: 19657638
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.
Lev-Ari S; Starr A; Vexler A; Karaush V; Loew V; Greif J; Fenig E; Aderka D; Ben-Yosef R
Anticancer Res; 2006; 26(6B):4423-30. PubMed ID: 17201164
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas.
Bloomer CW; Kenyon L; Hammond E; Hyslop T; Andrews DW; Curran WJ; Dicker AP
Am J Clin Oncol; 2003 Aug; 26(4):S75-80. PubMed ID: 12902861
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
[TBL] [Abstract][Full Text] [Related]
11. Claudin expression in rectal well-differentiated endocrine neoplasms (carcinoid tumors).
Ishida M; Kushima R; Okabe H
Oncol Rep; 2009 Jan; 21(1):113-7. PubMed ID: 19082451
[TBL] [Abstract][Full Text] [Related]
12. The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value.
Iino S; Abeyama K; Kawahara K; Yamakuchi M; Hashiguchi T; Matsukita S; Yonezawa S; Taniguchi S; Nakata M; Takao S; Aikou T; Maruyama I
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6179-88. PubMed ID: 15448005
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
[TBL] [Abstract][Full Text] [Related]
14. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
[TBL] [Abstract][Full Text] [Related]
16. COX-2 expression in chondrosarcoma: a role for celecoxib treatment?
Schrage YM; Machado I; Meijer D; Briaire-de Bruijn I; van den Akker BE; Taminiau AH; Kalinski T; Llombart-Bosch A; Bovée JV
Eur J Cancer; 2010 Feb; 46(3):616-24. PubMed ID: 20004565
[TBL] [Abstract][Full Text] [Related]
17. Expression of platelet-derived growth factor beta-receptors on stromal tissue cells in human carcinoid tumors.
Funa K; Papanicolaou V; Juhlin C; Rastad J; Akerström G; Heldin CH; Oberg K
Cancer Res; 1990 Feb; 50(3):748-53. PubMed ID: 2153446
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent.
Husvik C; Bryne M; Halstensen TS
Eur J Oral Sci; 2009 Oct; 117(5):528-35. PubMed ID: 19758248
[TBL] [Abstract][Full Text] [Related]
19. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
20. Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas.
Fjällskog ML; Hessman O; Eriksson B; Janson ET
Acta Oncol; 2007; 46(6):741-6. PubMed ID: 17653895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
